Tackling fake drugs needs technology and collaboration
Developing countries must be given all the scientific, technical and legal help they need to counter the growing trade in fake medicines.
The trade in counterfeit medicines is flourishing. This Spotlight looks at how can new technologies help to detect fakes; what will it take for developing countries to thwart the trade; and whether current policies targeting the right threat to patients' health.
(Photo credit: WHO/P. Virot)
Developing countries must be given all the scientific, technical and legal help they need to counter the growing trade in fake medicines.
Priya Shetty explores the tools and partnerships that help the public health community counter the threat of counterfeit medicines.
30 March 2011 | EN | ES | FR | 中文
The fight against counterfeits is deploying scanners, spectrometers and minilabs, but nothing can replace national regulatory systems, says Yojana Sharma.
30 March 2011 | EN | ES | FR | 中文
Both fake and substandard medicines threaten public health, and efforts to tackle them must put the focus on quality, says Leena Menghaney.
30 March 2011 | EN | ES | FR | 中文
Health and law enforcement organisations must work together to stop the spread of counterfeit medicines, says Aline Plançon.
30 March 2011 | EN | ES | FR | 中文
The Greater Mekong Subregion must build on current initiatives for a lasting response to fake and substandard drugs, says Charles Delacollette.
30 March 2011 | EN | ES | FR | 中文
12 March 2012
|
EN
7 October 2010
|
EN
28 August 2008
|
EN